The Dangerous Drugs Board (DDB) has updated the list of dangerous drugs during its 184th regular meeting last Thursday, June 27, at the DDB headquarters.
Presided by DDB Chairman Secretary Catalino Cuy, Board Members agreed to include plants that contain or are sources of substances listed in the 1961 Single Convention on Narcotic Drugs, 1971 Single Convention on Psychotropic Substances and those classified by the Board as dangerous drugs.
Member agencies of the Board gather for the 184th meeting of the Dangerous Drugs Board.
The DDB also classified GBL or Gamma-Butyrolactone as a dangerous drug. GBL has been reported to be used as a “date – rape drug,” as stronger doses of the substance can cause sleepiness, confusion, and dizziness, making victims vulnerable to sexual assault. It is usually mixed with alcoholic drinks and is used during parties where intake of illegal drugs such as methamphetamine hydrochloride (shabu) and methylenedioxy-methamphetamine (ecstasy) is prevalent.
The DDB has also approved a regulation involving the Sangguniang Kabataan. This aims to institutionalize a uniform preventive education program to engage SK Officials and youth leaders in the community to play an integral part in the government’s demand reduction program, and take the lead in conducting regular preventive education activities in their respective barangays and communities.
Six issuances in the form of Board Resolutions were also approved during the meeting. This includes the Protocol When Handling Children Allegedly Involved in Dangerous Drugs, and the Proposed Restructuring and Reclassification Plan of the Legal and Prosecution Service of the Philippine Drug Enforcement Agency to Strengthen and Rationalize its Legal and Prosecutorial Arm for the Facilitation of Proper and Effective Prosecution of Cases, among others.
RA 9165, otherwise known as the Dangerous Drugs Act of 2002, mandates the DDB to be the policy-making and strategy-formulating body on drug prevention and control. It also authorizes the DDB to reclassify, add to or remove from the list of Dangerous Drugs.
The DDB, with its 17-member agencies, meets periodically to discuss and review the national drug abuse situation and develop and strengthen the strategies and programs to address the drug problem.